Glial restricted progenitor cell therapy (Q Therapeutics)

N/A

Report date: 2024/10/29 14:24:40

Base Information

Drug NameGlial restricted progenitor cell therapy (Q Therapeutics)
Drug Alias NameHuman glial restricted progenitor cells based therapy (Q Therapeutics)Glial cell-based therapy (Q Therapeutics)hGRPs (Q Therapeutics)Q-Cells
ClassificationCell and gene therapy > Cell therapy > Somatic cell > Glial-restricted progenitors therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMyelitis, Transverse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesQ Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesQ Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisMyelitis, Transverse
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A